KFO
Kopp Family Office Portfolio holdings
AUM
$155M
This Quarter Return
+23.74%
1 Year Return
+12.37%
3 Year Return
+32.09%
5 Year Return
+62.77%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+27%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
10.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$17.6M |
| 2 |
Vericel Corp
VCEL
|
$4.61M |
| 3 |
FIVE9
FIVN
|
$2.77M |
| 4 |
NeoGenomics
NEO
|
$92.9K |
Top Sells
| 1 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$6.17M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$135K |
Sector Composition
| 1 | Healthcare | 95.61% |
| 2 | Technology | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.14B
| $144M | 78.03% |
4,661,835
+3,000
| +0.1% | +$92.9K |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $17.6M | 9.5% |
+316,325
| New | +$17.6M |
|
|
3
Vericel Corp
VCEL
$1.75B
| $15M | 8.08% |
1,082,155
+333,900
| +45% | +$4.61M |
|
|
4
FIVE9
FIVN
$2.04B
| $7.08M | 3.83% |
63,995
+25,000
| +64% | +$2.77M |
|
|
XENT
5
DELISTED
Intersect ENT, Inc
XENT
| $1.05M | 0.57% |
77,630
-10,000
| -11% | -$135K |
|
|
SRGA
6
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| – | – |
-3,607,699
| Closed | -$6.17M |
|